Chondros Dimitrios 4
4 · HALOZYME THERAPEUTICS INC · Filed Jun 3, 2019
Insider Transaction Report
Form 4
Chondros Dimitrios
SVP, Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2019-06-01+2,043→ 40,618 total - Tax Payment
Common Stock
2019-06-01$14.75/sh−706$10,414→ 39,912 total - Exercise/Conversion
Restricted Stock Units
2019-06-01−2,043→ 4,084 totalExercise: $0.00→ Common Stock (2,043 underlying)
Footnotes (2)
- [F1]The reported disposition of 706 shares represents the shares that were withheld by the issuer as payment for minimum statutory tax withholding obligations.
- [F2]This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.